AstraZeneca
Tracked across 16 events · 135 articles · First seen Jan 08, 2025 · Last active May 28, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Tech
The United States — Food and Drug Administration has approved Trastuzumab deruxtecan, a drug jointly developed and commercialized by AstraZeneca and Daiichi Sankyo, for two new indications in the treatment of HER2-positive early breast cancer.…
Impact: AstraZeneca, in collaboration with Daiichi Sankyo, received FDA approval for Trastuzumab deruxtecan for new breast cancer indications, which is a significant positive development for the company's product portfolio and revenue.
May 15, 2026 · 7 articles
Tech
Trastuzumab deruxtecan (fam-trastuzumab deruxtecan-nxki), a HER2-directed antibody drug conjugate developed by Daiichi Sankyo and AstraZeneca, has received two new approvals from the United States — Food and Drug Administration. These approvals are for the neoadjuvant…
Impact: AstraZeneca jointly developed and commercialized Trastuzumab deruxtecan with Daiichi Sankyo. The new approvals trigger milestone payments from AstraZeneca to Daiichi Sankyo and reinforce Trastuzumab deruxtecan's role in breast cancer treatment.
May 15, 2026 · 9 articles
International
Impact: AstraZeneca announced a significant investment of $15 billion in China through 2030 to expand its medicines manufacturing and research, demonstrating confidence in the Chinese market.
Jan 30, 2026 · 9 articles
Tech
Impact: AstraZeneca has partnered with Quell Therapeutics to develop therapies for inflammatory bowel disease, indicating its interest in the field of immune tolerance.
Oct 06, 2025 · 6 articles
Business
Impact: Maria G. Belvisi previously served as Senior Vice President, Research & Development, Respiratory & Immunology at AstraZeneca, where she led the development of tozorakimab.
Apr 10, 2026 · 6 articles
Business
Impact: AstraZeneca is implicated for allegedly reducing financial commitments to Tempus AI through a questionable 'pass-through payment' arrangement with Pathos AI, Inc., raising concerns about Tempus AI's revenue prospects.
Jun 18, 2025 · 6 articles
Domestic
Impact: AstraZeneca, among other pharmaceutical companies, had previously announced investments in U.S. production due to the threat of tariffs, but the new, higher tariffs introduce further uncertainty.
Sep 26, 2025 · 7 articles
Regulatory
Impact: AstraZeneca, like Pfizer, previously agreed to lower prescription drug costs for United States — Medicaid, contributing to the broader context of the Trump administration's efforts to control drug prices.
Nov 06, 2025 · 6 articles
International
Impact: AstraZeneca's CEO, Pascal Soriot, is part of the business delegation, suggesting potential for increased pharmaceutical and healthcare sector cooperation with China.
Jan 27, 2026 · 34 articles
Regulatory
Impact: AstraZeneca is mentioned as a collaborator with Innate Pharma, specifically on the monalizumab antibody.
Apr 02, 2026 · 7 articles
Business
Impact: AstraZeneca is mentioned as a collaborator with Innate Pharma, specifically on the monalizumab antibody for non-small cell lung cancer.
Apr 08, 2026 · 6 articles
Regulatory
Tracy Beth Høeg, the acting head of the United States — Food and Drug Administration's drug center, is expected to leave the agency shortly after Commissioner Marty Makary resigned. This departure is part of a…
Impact: AstraZeneca is mentioned as one of the companies whose approved protective RSV treatments for infants faced safety questions initiated by Tracy Beth Høeg.
May 15, 2026 · 6 articles
Regulatory
Impact: AstraZeneca is mentioned as a biopharmaceutical company with whom Innate Pharma has established collaborations, including the development of monalizumab.
Apr 13, 2026 · 6 articles
Business
Impact: AstraZeneca is mentioned as one of the industry leaders that Kaltura and PathFactory already serve.
Apr 17, 2026 · 7 articles
95
AstraZeneca received approval United States — Food and Drug AdministrationFDA Approves ENHERTU for...
80
AstraZeneca paid milestone payments Daiichi SankyoEnhertu FDA Approvals for...
NEWSDESK
Track AstraZeneca live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard